Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DB 289

Known as: 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, DB-289, DB289 cpd 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Highly Cited
2005
Highly Cited
2005
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
2004
2004
DB75 (2,5-bis(4-amidinophenyl)furan) is a promising antimicrobial agent against African trypanosomiasis and Pneumocystis carinii… Expand
Review
2003
Review
2003
  • C. Yeates
  • IDrugs : the investigational drugs journal
  • 2003
  • Corpus ID: 40628056
DB-289, an oral diamidoxime prodrug of DB-75 from the University of North Carolina, Georgia State University, Auburn University… Expand
2002
2002
A novel prodrug [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime (DB289)] of the promising antimicrobial agent, 2,5-bis(4… Expand